Giulia Marvaso

Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy

Elise De Bleser, Barbara Alicja Jereczek‐Fossa, Thomas Zilli et al. · European Urology · 2019 · 139 citations · Full text

Medicine, Oncology, Urology +17

Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)

Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti et al. · Journal of Clinical Oncology · 2023 · 126 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients

Cirino Botta, Vito Barbieri, Domenico Ciliberto et al. · Cancer Biology & Therapy · 2013 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes

Barbara Alicja Jereczek‐Fossa, Giuseppe Fanetti, Cristiana Fodor et al. · Clinical Genitourinary Cancer · 2017 · 77 citations

Medicine, Radiation Oncology, Urology +13

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial

Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni et al. · The Lancet Oncology · 2025 · 77 citations

Medicine, Oncology, Urology +11